Raymond James raised the price target for the The Clorox Company (NYSE:CLX) stock to ‘an Outperform’. The rating was released on June 13, 2023, according to finviz. We previously noted in another research note published on February 04, 2023 by Wells Fargo that reiterated the stock to an Underweight with a price target of $150 for CLX stock. The research report from UBS has reiterated the stock to Sell, with a price target set at $148. The stock was reiterated by Morgan Stanley, who disclosed in a research note on February 04, 2023, to Underweight and set the price objective to $140.
